William E. Rote insider trades: Travere Therapeutics (TVTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | TVTX | ↓ Sell | 209,048 | $62.83 | $13.1M | Direct | Sep 17, 2026 (1d) |
| May 6, 2026 | TVTX | ↓ Sell | 2,763 | $43.95 | $121K | Direct | May 6, 2026 (0d) |
| Apr 22, 2026 | TVTX | ↓ Sell | 9,100 | $39.09 | $356K | Direct | Apr 23, 2026 (1d) |
| Feb 3, 2026 | TVTX | ↓ Sell | 12,446 | $32.87 | $409K | Direct | Feb 3, 2026 (0d) |
| May 5, 2025 | TVTX | ↓ Sell | 3,198 | $21.05 | $67K | Direct | May 5, 2025 (0d) |
| Feb 12, 2025 | TVTX | ↓ Sell | 5,200 | $23.53 | $122K | Direct | Feb 12, 2025 (0d) |
| Feb 3, 2025 | TVTX | ↓ Sell | 8,951 | $19.78 | $177K | Direct | Feb 4, 2025 (1d) |
| Jan 22, 2025 | TVTX | ↓ Sell | 2,437 | $19.46 | $47K | Direct | Jan 23, 2025 (1d) |
| Sep 9, 2024 | TVTX | ↓ Sell | 4,387 | $11.52 | $51K | Direct | Sep 9, 2024 (0d) |
| Feb 1, 2024 | TVTX | ↓ Sell | 4,764 | $8.71 | $41K | Direct | Feb 2, 2024 (1d) |
| Jan 23, 2024 | TVTX | ↓ Sell | 2,062 | $8.96 | $18K | Direct | Jan 25, 2024 (2d) |
| Sep 5, 2023 | TVTX | ↓ Sell | 1,815 | $14.71 | $27K | Direct | Sep 5, 2023 (0d) |
| May 10, 2023 | TVTX | ↓ Sell | 825 | $16.59 | $14K | Direct | May 12, 2023 (2d) |
| Feb 1, 2023 | TVTX | ↓ Sell | 2,590 | $22.25 | $58K | Direct | Feb 2, 2023 (1d) |
| Jan 24, 2023 | TVTX | ↓ Sell | 2,062 | $21.50 | $44K | Direct | Jan 26, 2023 (2d) |
| May 11, 2022 | TVTX | ↓ Sell | 1,563 | $21.71 | $34K | Direct | May 12, 2022 (1d) |
| Jan 31, 2022 | TVTX | ↓ Sell | 1,125 | $27.40 | $31K | Direct | Feb 2, 2022 (2d) |
| Jan 24, 2022 | TVTX | ↓ Sell | 1,875 | $24.98 | $47K | Direct | Jan 26, 2022 (2d) |
| Jan 11, 2022 | TVTX | ↓ Sell | 2,500 | $27.40 | $69K | Direct | Jan 12, 2022 (1d) |
| Aug 17, 2021 | TVTX | ↓ Sell | 1,407 | $17.12 | $24K | Direct | Aug 17, 2021 (0d) |
| May 12, 2021 | TVTX | ↓ Sell | 3,125 | $19.30 | $60K | Direct | May 13, 2021 (1d) |
| Feb 18, 2021 | TVTX | ↓ Sell | 2,500 | $28.01 | $70K | Direct | Feb 18, 2021 (0d) |
| Feb 8, 2021 | TVTX | ↓ Sell | 4,500 | $31.50 | $142K | Direct | Feb 9, 2021 (1d) |
| Feb 3, 2021 | TVTX | ↓ Sell | 3,625 | $28.91 | $105K | Direct | Feb 3, 2021 (0d) |
| Feb 2, 2021 | TVTX | ↓ Sell | 3,625 | $30.75 | $111K | Direct | Feb 2, 2021 (0d) |
| Nov 16, 2020 | RTRX | ↓ Sell | 2,500 | $23.96 | $60K | Direct | Nov 17, 2020 (1d) |
| Nov 13, 2020 | RTRX | ↓ Sell | 2,500 | $23.62 | $59K | Direct | Nov 13, 2020 (0d) |
| Sep 23, 2020 | RTRX | ↓ Sell | 1,500 | $18.48 | $28K | Direct | Sep 23, 2020 (0d) |
| Sep 22, 2020 | RTRX | ↓ Sell | 1,500 | $18.59 | $28K | Direct | Sep 22, 2020 (0d) |
| May 12, 2020 | RTRX | ↓ Sell | 2,152 | $16.28 | $35K | Direct | May 13, 2020 (1d) |
| Mar 10, 2020 | RTRX | ↓ Sell | 3,250 | $14.87 | $48K | Direct | Mar 12, 2020 (2d) |
| Feb 18, 2020 | RTRX | ↓ Sell | 2,500 | $16.64 | $42K | Direct | Feb 19, 2020 (1d) |
| May 15, 2019 | RTRX | ↓ Sell | 1,625 | $17.77 | $29K | Direct | May 16, 2019 (1d) |
| Feb 19, 2019 | RTRX | ↓ Sell | 2,500 | $21.48 | $54K | Direct | Feb 20, 2019 (1d) |
| Feb 12, 2019 | RTRX | ↓ Sell | 1,985 | $21.44 | $43K | Direct | Feb 13, 2019 (1d) |
| Nov 15, 2018 | RTRX | ↓ Sell | 5,000 | $24.03 | $120K | Direct | Nov 16, 2018 (1d) |
| Feb 14, 2018 | RTRX | ↓ Sell | 1,034 | $21.50 | $22K | Direct | Feb 16, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About William E. Rote's insider trades
William E. Rote is Chief Research Officer at Travere Therapeutics (TVTX). Since Feb 14, 2018, William has reported no open-market purchases and 37 sales worth $15.9M on SEC Form 4. In the last 12 months: 4 sales ($14.0M).
Their filings also include grants and awards (23 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.